Vertex: Q2 Earnings Snapshot

Vertex Pharmaceuticals reported second-quarter profit of $1.1 billion with $4.31 per-share net income, adjusted to $4.73, below Wall Street's $4.79 estimate. Revenue of $3.33 billion exceeded forecasts, and the company projects full-year revenue between $13.1 billion and $13.2 billion.